These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23326330)

  • 1. Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25.
    Zhang L; Xiao R; Xiong J; Leng J; Ehtisham A; Hu Y; Ding Q; Xu H; Liu S; Wang J; Tang DG; Zhang Q
    PLoS One; 2013; 8(1):e52384. PubMed ID: 23326330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezrin is a key molecule in the metastasis of MOLT4 cells induced by CCL25/CCR9.
    Zhou B; Leng J; Hu M; Zhang L; Wang Z; Liu D; Tong X; Yu B; Hu Y; Deng C; Liu Y; Zhang Q
    Leuk Res; 2010 Jun; 34(6):769-76. PubMed ID: 20036004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein-actin association through ERM family proteins: a role in P-glycoprotein function in human cells of lymphoid origin.
    Luciani F; Molinari A; Lozupone F; Calcabrini A; Lugini L; Stringaro A; Puddu P; Arancia G; Cianfriglia M; Fais S
    Blood; 2002 Jan; 99(2):641-8. PubMed ID: 11781249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular distribution of ezrin/radixin/moesin and their roles in the cell surface localization and transport function of P-glycoprotein in human colon adenocarcinoma LS180 cells.
    Kobori T; Tameishi M; Tanaka C; Urashima Y; Obata T
    PLoS One; 2021; 16(5):e0250889. PubMed ID: 33974673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific killing of CCR9 high-expressing acute T lymphocytic leukemia cells by CCL25 fused with PE38 toxin.
    Hu Y; Zhang L; Wu R; Han R; Jia Y; Jiang Z; Cheng M; Gan J; Tao X; Zhang Q
    Leuk Res; 2011 Sep; 35(9):1254-60. PubMed ID: 21295855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt5a and CCL25 promote adult T-cell acute lymphoblastic leukemia cell migration, invasion and metastasis.
    Deng X; Tu Z; Xiong M; Tembo K; Zhou L; Liu P; Pan S; Xiong J; Yang X; Leng J; Zhang Q; Xiao R; Zhang Q
    Oncotarget; 2017 Jun; 8(24):39033-39047. PubMed ID: 28380463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25.
    Li J; Muhammad J; Xie T; Sun J; Lei Y; Wei Z; Pan S; Qin H; Shao L; Jiang D; Zhang Q
    Mol Immunol; 2021 Dec; 140():267-275. PubMed ID: 34808497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library.
    Zhao L; Pan Y; Gang Y; Wang H; Jin H; Tie J; Xia L; Zhang Y; He L; Yao L; Qiao T; Li T; Liu Z; Fan D
    J Biol Chem; 2009 Sep; 284(39):26273-85. PubMed ID: 19638344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of Induction of P-gp Activity During MET Induced by DEX in Lung Cancer Cell Line.
    Liu W; Zhang X; Sunakawa H; Perera LMB; Martha L; Mizoi K; Ogihara T
    J Pharm Sci; 2024 Jun; 113(6):1674-1681. PubMed ID: 38432625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CC chemokine ligand 25 enhances resistance to apoptosis in CD4+ T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation.
    Qiuping Z; Jei X; Youxin J; Wei J; Chun L; Jin W; Qun W; Yan L; Chunsong H; Mingzhen Y; Qingping G; Kejian Z; Zhimin S; Qun L; Junyan L; Jinquan T
    Cancer Res; 2004 Oct; 64(20):7579-87. PubMed ID: 15492285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion.
    Johnson-Holiday C; Singh R; Johnson EL; Grizzle WE; Lillard JW; Singh S
    World J Surg Oncol; 2011 May; 9():46. PubMed ID: 21539750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.
    Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R
    PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
    Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
    World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of breast cancer resistance protein and P-glycoprotein by ezrin, radixin and moesin in lung, intestinal and renal cancer cell lines.
    Yano K; Okabe C; Fujii K; Kato Y; Ogihara T
    J Pharm Pharmacol; 2020 Apr; 72(4):575-582. PubMed ID: 31975441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
    Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
    Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
    Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-138 might reverse multidrug resistance of leukemia cells.
    Zhao X; Yang L; Hu J; Ruan J
    Leuk Res; 2010 Aug; 34(8):1078-82. PubMed ID: 19896708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversion of P-glycoprotein-mediated multidrug resistance in human leukemic cell line by carnosic acid.
    Yu XN; Chen XL; Li H; Li XX; Li HQ; Jin WR
    Chin J Physiol; 2008 Dec; 51(6):348-56. PubMed ID: 19280878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.